| Source: |
| Type: measurement |
| Bioavailability (usually in %) absorbed by the body. |
| 6862- | FBZ, | Research: The Urgent Need for Clinical Studies to Evaluate the Anti-Tumor Efficacy of Fenbendazole |
| - | Review, | Var, | NA |
| 6861- | FBZ, | Fenbendazole pharmacokinetics, metabolism, and potentiation in horses |
| - | in-vivo, | Nor, | NA |
| 2494- | FBZ, | Oral Fenbendazole for Cancer Therapy in Humans and Animals |
| - | Review, | Var, | NA |
| 6910- | FIS, | Exploring the therapeutic promise of fisetin: molecular mechanisms and clinical aspects in lung cancer |
| - | in-vitro, | Lung, | NA |
| - | in-vivo, | Nor, | NA |
| 2854- | FIS, | New Perspectives for Fisetin |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA |
| 2861- | FIS, | The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress |
| - | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
| 2824- | FIS, | Fisetin in Cancer: Attributes, Developmental Aspects, and Nanotherapeutics |
| - | Review, | Var, | NA |
| 2830- | FIS, | Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent |
| - | Review, | Var, | NA |
| 2843- | FIS, | Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential |
| - | Review, | Var, | NA |
| 6924- | Flav, | Plant Flavonoids: Chemical Characteristics and Biological Activity |
| - | Review, | Nor, | NA |
| 2642- | Flav, | QC, | Api, | KAE, | MCT | In Vitro–In Vivo Study of the Impact of Excipient Emulsions on the Bioavailability and Antioxidant Activity of Flavonoids: Influence of the Carrier Oil Type |
| - | in-vitro, | Nor, | NA | - | in-vivo, | Nor, | NA |
| 6979- | Form, | Pharmacokinetics and Bioavailability of the Isoflavones Formononetin and Ononin and Their in Vitro Absorption in Ussing Chamber and Caco-2 Cell Models |
| - | in-vitro, | Colon, | Caco-2 |
| 6981- | Form, | Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | PSA, | NA |
| 6982- | Form, | Formononetin: A Review of Its Anticancer Potentials and Mechanisms |
| - | Review, | Var, | NA |
| 6992- | Form, | Formononetin: pharmacological properties and therapeutic potential |
| - | Review, | Nor, | NA |
| 6997- | Form, | PI, | Formononetin–piperine–phospholipid complex: enhancement of anti-osteoporotic activity and bioavailability in bone marrow in rats |
| - | in-vivo, | ostP, | NA |
| 8303- | FS, | The relative bioavailability of enterolignans in humans is enhanced by milling and crushing of flaxseed |
| - | Trial, | Nor, | NA |
| 8306- | FS, | lign, | Flax Lignans: From Biosynthetic Regulation to Biological Activities |
| - | Review, | Nor, | NA |
| 8588- | FS, | Tam, | Dietary flaxseed and tamoxifen affect the inflammatory microenvironment in vivo in normal human breast tissue of postmenopausal women |
| - | in-vivo, | BC, | NA |
| 8584- | FS, | Anti-Oxidant and Anti-Cancer Properties of Flaxseed |
| - | Review, | Nor, | NA |
| 8579- | FS, | IP6, | Flaxseed: a potential source of food, feed and fiber |
| - | Review, | Nor, | NA | - | Review, | IBD, | NA |
| 8586- | FS, | The Role of Flaxseed in Improving Human Health |
| - | Review, | Nor, | NA |
| 8590- | FS, | The Effect of Flaxseed in Breast Cancer: A Literature Review |
| - | Review, | BC, | NA |
| 7012- | Fuc, | Fucoidan: A promising natural therapeutic agent for protecting human kidney health |
| - | Review, | EC, | NA |
| 7013- | Fuc, | Fucoidan-based nanoparticles for colorectal cancer therapy: Mechanisms and preclinical insights |
| - | Review, | CRC, | NA |
| 7016- | Fuc, | Therapies from Fucoidan: New Developments |
| - | Review, | Var, | NA |
| 7026- | Fuc, | Fucoidan |
| - | Review, | AD, | NA |
| 7018- | Fuc, | Absorption Study of Mozuku Fucoidan in Japanese Volunteers |
| - | Trial, | Nor, | NA |
| 7025- | Fuc, | Pilot clinical study to evaluate the anticoagulant activity of fucoidan |
| - | Human, | Nor, | NA |
| 6998- | Fuc, | Detection of Fucoidan in Urine after Oral Intake of Traditional Japanese Seaweed, Okinawa mozuku (Cladosiphon okamuranus Tokida) |
| - | Human, | Nor, | NA |
| 7006- | Fuc, | Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug—A Review |
| - | Review, | Var, | NA |
| 4016- | FulvicA, | Shilajit: A Natural Phytocomplex with Potential Procognitive Activity |
| - | Review, | AD, | NA |
| 4027- | FulvicA, | Mummy Induces Apoptosis Through Inhibiting of Epithelial-Mesenchymal Transition (EMT) in Human Breast Cancer Cells |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Nor, | MCF10 |
| 947- | GA, | Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN/AKT/HIF-1α/VEGF signaling pathway in ovarian cancer cells |
| - | in-vitro, | Ovarian, | OVCAR-3 | - | in-vitro, | Melanoma, | A2780S | - | in-vitro, | Nor, | IOSE364 | - | Human, | NA, | NA |
| 7038- | GA, | Gallic acid for cancer therapy: Molecular mechanisms and boosting efficacy by nanoscopical delivery |
| - | Review, | Var, | NA |
| 7044- | GA, | QC, | Inhibitory effects of gallic acid and quercetin on UDP-glucose dehydrogenase activity |
| - | in-vitro, | BC, | MCF7 |
| 7027- | GA, | Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans |
| - | Human, | Nor, | NA |
| 1773- | GA, | Impact of Gallic Acid on Gut Health: Focus on the Gut Microbiome, Immune Response, and Mechanisms of Action |
| - | Review, | Var, | NA |
| 7069- | GABA, | United States Pharmacopeia (USP) Safety Review of Gamma-Aminobutyric Acid (GABA) |
| - | Review, | Nor, | NA |
| 7066- | GamB, | Unravelling the Therapeutic Potential of Gambogic Acid: Deciphering Its Molecular Mechanism of Action and Emerging Role as an Anticancer Xanthone |
| - | Review, | Var, | NA |
| 7065- | GamB, | Gambogic acid: A review of its pharmacological mechanisms against cancer |
| - | Review, | Var, | NA |
| 5148- | GamB, | Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics |
| - | Review, | Var, | NA |
| 7087- | GAR, | Garcinol as an Epigenetic Modulator: Mechanisms of Anti-Cancer Activity and Therapeutic Potential |
| - | Review, | Var, | NA |
| 7086- | GAR, | Garcinol: An emerging epigenetic modifier with versatile anticancer properties |
| - | Review, | Var, | NA |
| - | in-vivo, | Nor, | NA |
| 7094- | GAR, | A multi-targeted approach of garcinol for obesity intervention: Mechanistic insights and possible clinical applications |
| - | Review, | Nor, | NA |
| 7205- | GBE, | Exploring the multifaceted role of ginkgolides and bilobalide from Ginkgo biloba in mitigating metabolic disorders |
| - | Review, | AD, | NA |
| 7127- | Ge-132, | Synthesis and Evaluation of Novel Organogermanium Sesquioxides As Antitumor Agents |
| - | vitro+vivo, | Var, | NA |
| 7098- | Geld, | Geldanamycins: Potent Hsp90 Inhibitors with Significant Potential in Cancer Therapy |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:792 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid